Cargando…
Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
We evaluated the efficacy of dose de-escalation to the normal larynx using conformal radiotherapy (CRT) for T1/T2 glottic cancer. For conventional RT (2DRT, n = 38), the laryngeal box received a median equivalent dose in 2 Gy fractions (EQD2) of 66 Gy. For CRT (n = 42; 3D-CRT, 20; intensity-modulate...
Autores principales: | Kim, Jun Won, Byeon, Hyung Kwon, Choi, Hong-Shik, Lee, Ik Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691141/ https://www.ncbi.nlm.nih.gov/pubmed/29147004 http://dx.doi.org/10.1038/s41598-017-15974-6 |
Ejemplares similares
-
Publisher Correction: Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
por: Kim, Jun Won, et al.
Publicado: (2018) -
Outcomes of radiotherapy in patients with glottic larynx cancer T1 and T2
por: Flores, Jesús M, et al.
Publicado: (2007) -
Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer—A Multicenter Study
por: Elicin, Olgun, et al.
Publicado: (2019) -
On Sub-Glottic Œdema of the Larynx and Permanent Stricture, Following Typhus
por: Russell, James B.
Publicado: (1871) -
Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer
por: Hong, Chae-Seon, et al.
Publicado: (2016)